<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="71.887,75.339,78.226,83.175,88.125,92.608,94.393,98.311,103.261,108.21,110.631,115.58,117.353,124.723,129.206,131.627,136.577,138.998,143.481,145.245,150.195,154.113,155.904,160.387,163.274,166.161,169.613,172.034,176.983,181.933,184.82,188.738,193.687,195.474,198.361,203.31,205.111,207.999,212.948,216.866,218.66,223.144,227.627,231.079,233.5,238.449,243.398,246.85,248.594,251.481,255.964,260.913,264.832,268.284,270.079,275.029,277.916,279.717,283.636,288.119,293.068,296.986,300.905,304.357,307.809,309.594,312.015" y="39.74800000000005" svg_rhmargin="316.964" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">study could mainly be attributed to the various types of cancers in</text>
  <text x="71.887,74.774,79.723,82.144,85.596,88.554,95.924,99.843,102.73,107.213,110.1,114.583,119.533,124.016,126.437,130.92,134.372,136.793,140.245,142.666,145.585,151.467,155.95,160.9,164.818,169.76700000000002,172.74,175.628,180.577,185.06,188.978,191.866,196.815,200.733,204.185,206.606,209.533,214.482,219.432,222.884,225.803,233.173,237.092,239.979,244.462,247.349,251.832,256.782,261.265,263.686,268.169,271.621,274.042,277.49399999999997,280.453,283.905,288.854,293.337,297.82,301.739,305.191,308.078,311.996" y="50.690000000000055" svg_rhmargin="316.945" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">this meta-analysis. Taken together, our meta-analysis suggested</text>
  <text x="71.887,74.774,79.723,84.206,87.093,88.837,93.787,100.225,106.106,111.05499999999999,112.818,120.188,122.609,127.092,132.041,134.928,136.684,141.634,145.552,147.286,152.235,155.687,159.606,164.555,166.278,170.761,174.213,175.972,180.455,185.40400000000002,187.14,192.09,197.039,199.926,204.409,208.893,213.842,217.294,221.777,226.727,229.147,233.065,234.818,239.767,243.219,248.169,252.652,257.601,262.551,266.003,268.89,271.311,275.229,276.996,281.946,284.366,289.316,296.686,301.169,304.621,309.571,313.489" y="61.63099999999997" svg_rhmargin="316.941" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">that PVT1 might be used as an unfavorable prognostic biomarker</text>
  <text x="71.887,74.774,79.723,83.175,86.173,93.543,98.492,101.944,104.831,107.829,111.747,116.23,121.18,125.098,129.016,132.468,135.92" y="72.62900000000002" svg_rhmargin="138.341" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">for most cancers.</text>
  <text x="71.887,77.802,80.75500000000001,85.493,91.21,93.964,102.633,105.387,109.031,114.549,118.193,120.947,126.664,132.579" y="93.26599999999996" svg_rhmargin="137.803" style="fill:#171615;font-family:NCNDPH+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">5. Limitations</text>
  <text x="71.887,76.37,80.288,84.771,88.689,92.141,96.625,99.046,101.31,103.73,106.151,113.522,115.942,118.83,123.313,126.2,128.621,133.57,138.52,141.972,144.225,151.595,156.545,159.997,162.88400000000001,165.144,170.094,174.012,176.199,179.086,183.569,188.518,192.437,197.38600000000002,199.612,202.033,206.983,209.87,214.81900000000002,217.073,221.557,225.475,229.393,234.343,239.292,244.241,247.12800000000001,249.387,256.291,261.241,263.661,266.082,270.0,272.233,274.654,279.604,282.491,286.409,289.861,294.81,298.262,302.181,305.068,307.489,312.438" y="109.25400000000002" svg_rhmargin="316.921" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Several limitations must be taken into account while interpreting</text>
  <text x="71.887,74.774,79.723,83.641,88.724,92.643,97.592,102.541,106.46,108.881,113.83,117.282,119.703,124.652,129.602,133.054,138.159,143.109,145.996,151.085,153.972,158.922,161.342,164.794,169.907,177.277,181.196,184.083,188.566,191.453,195.936,200.886,205.369,207.79,212.273,215.725,218.146,221.598,224.019,229.093,234.042,236.463,239.915,243.367,246.254,248.675,253.158,255.57899999999998,260.727,268.097,273.046,276.498,279.385,284.48,286.901,291.851,295.769,298.19,303.139,308.089,312.007" y="120.19500000000005" svg_rhmargin="316.956" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">the conclusions of this meta-analysis. Firstly, most included</text>
  <text x="71.887,75.339,78.226,83.175,88.125,90.545,94.464,97.916,103.86,110.764,114.683,118.135,122.05300000000001,127.955,130.842,134.294,139.243,146.613,152.559,158.997,163.946,166.367,171.317,175.8,178.221,184.136,188.619,193.568,198.51700000000002,204.432,209.381,214.331,216.752,221.235,227.165,232.114,237.064,240.982,246.894,253.798,258.281,261.733,267.643,270.53,273.982,278.931,286.301,292.19,295.642,300.126,305.075,309.558,314.508" y="131.13699999999994" svg_rhmargin="316.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">studies were from China, and only one was from Japan;</text>
  <text x="71.887,74.774,79.723,83.641,87.093,91.012,93.899,98.848,102.3,106.219,108.64,111.91,116.86,121.809,125.261,128.464,133.413,137.896,140.784,145.267,148.532,155.903,158.324,162.807,167.756,170.643,173.873,178.822,183.772,186.659,189.916,194.866,198.78400000000002,201.992,206.475,208.896,213.846,218.795,223.278,225.699,228.12,232.603,235.836,240.319,245.269,250.218,252.639,255.06,258.978,263.461,268.411,270.832,274.75,277.171,280.452,284.935,288.853,292.771,297.721,302.67,307.62,310.041,314.524" y="142.07799999999997" svg_rhmargin="316.945" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">therefore, our data might not be globally applicable. Secondly,</text>
  <text x="71.887,76.836,81.785,84.206,88.68900000000001,90.538,93.99,101.361,105.844,108.265,110.686,112.534,115.986,120.47,127.84,132.789,135.21,139.12800000000001,140.993,144.445,146.866,150.785,154.703,156.583,161.533,164.42,166.278,170.196,174.679,179.628,183.547,187.465,190.917,192.752,195.639,200.123,205.072,208.99,210.894,215.377,220.326,225.275,227.108,232.057,237.006,244.377,249.326,253.244,256.696,258.571,265.475,269.958,273.41,275.239,277.66,282.609,286.527,288.948,293.898,298.847,302.765,307.714,309.593,312.014" y="153.077" svg_rhmargin="316.963" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">only small sample size of cancer type and number was included in</text>
  <text x="71.887,74.774,79.723,82.144,85.596,88.44,95.81,99.729,102.616,107.099,109.986,114.469,119.419,123.902,126.323,130.806,134.258,136.679,140.131,142.552,145.415,148.867,153.816,156.583,159.004,163.487,166.939,171.422,175.341,178.793,181.68,185.132,189.05,193.533,195.954,199.872,202.73,206.182,209.069,214.019,218.968,221.389,225.307,228.759,231.585,238.489,243.439,248.388,250.809,255.758,258.57,263.52,267.438,270.249,275.198,279.117,283.035,286.953,290.405,293.857,298.34,301.792,306.275,309.139,312.027" y="164.01800000000003" svg_rhmargin="316.976" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">this meta-analysis, so larger-scale studies would be necessary to</text>
  <text x="71.887,76.37,80.288,83.74,86.161,89.048,93.531,100.233,103.12,108.069,111.98700000000001,118.657,123.607,128.556,131.443,135.927,138.347,143.297,147.215,152.16400000000002,158.795,162.247,166.165,169.617,174.567,176.988,179.875,183.327,185.748,192.47,198.352,203.301,205.722,209.174,214.124,216.544,221.028,223.44899999999998,230.113,233.0,237.95,241.868,248.538,252.456,255.908,258.329,261.216,265.135,268.587,271.008,275.491,282.213,285.1,290.049,293.501,300.127,305.077,307.498,311.981" y="174.96000000000004" svg_rhmargin="316.93" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">verify the obtained results. Thirdly, the criteria for high</text>
  <text x="71.887,75.805,80.754,85.704,89.156,93.074,96.526,99.978,102.399,107.348,112.297,115.596,120.545,122.966,125.853,128.74,132.658,136.11,140.029,144.978,148.306,152.79,160.16,165.109,170.059,174.542,177.842,180.729,185.679,189.597,193.049,196.967,200.236,203.688,206.575,211.524,216.474,218.894,222.813,226.265,228.68599999999998,232.039,236.522,241.472,246.42100000000002,249.67,252.091,254.978,258.288,265.192,269.675,273.127,276.429,281.379,283.8" y="185.95799999999997" svg_rhmargin="286.687" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">expression differed among these studies, and it was dif</text>
  <text x="286.697" y="185.95799999999997" svg_rhmargin="291.646" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="291.629,295.547,300.497,302.918,305.805,309.147,312.034" y="185.95799999999997" svg_rhmargin="316.983" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cult to</text>
  <text x="71.887,76.836,81.785,84.673,89.156,91.577,96.526,98.191,101.078,106.028,109.94600000000001,111.683,115.136,119.619,126.989,130.907,132.546,137.029,141.513,143.933,148.883,152.801,155.22199999999998,156.923,163.361,168.31,173.26,176.712,180.63,185.579,190.529,194.447,199.396,202.283,204.704,209.188,211.60899999999998,213.33,216.217,221.167,224.619,227.506,232.455,236.373,239.825,241.506,244.958,247.845,252.794,257.744,262.22700000000003,263.956,270.86,273.28,275.701,278.122,279.829,284.779,288.697,290.374,295.323,299.241,303.16,308.109,312.027" y="196.899" svg_rhmargin="316.976" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">obtain the same value. Consequently, further study will be needed</text>
  <text x="71.887,74.774,79.723,82.715,86.633,91.583" y="207.841" svg_rhmargin="96.532" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">to con</text>
  <text x="96.548" y="207.841" svg_rhmargin="101.497" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="101.481,104.933,112.30300000000001,115.314,118.201,123.151,127.069,130.054,132.941,137.89,142.84,146.758,149.645,152.066,157.015,161.964,164.976,169.925,172.812,175.804,180.754,187.191,193.073,198.02200000000002,201.032,203.453,208.40200000000002,211.407,215.89,220.373,223.825,226.246,231.195,236.145,239.597,242.587,246.505,250.988,255.938,259.856,263.774,267.226,270.678" y="207.841" svg_rhmargin="273.099" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">rm the function of PVT1 in various cancers.</text>
  <text x="71.887,77.802,80.75500000000001,85.493,92.591,98.308,104.223,109.741,112.495,118.411,123.635,126.389,132.106,138.021" y="234.48800000000006" svg_rhmargin="143.245" style="fill:#171615;font-family:NCNDPH+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">6. Conclusions</text>
  <text svg_rhmargin="157.008" x="71.887,77.768,82.252,87.201,91.119,96.068,102.897,105.784,110.733,115.216,119.134,122.022,126.971,130.889,134.341,136.762,143.657,148.607,153.556,157.008" y="250.476" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Taken together, our </text>
  <text x="163.843" y="250.476" svg_rhmargin="168.792" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="168.832,173.781,178.731,181.152,186.101,190.584,194.036,200.862,203.283,208.233,213.182,215.603,219.521,224.004,226.892,230.81,237.655,240.542,245.491,249.974,252.861,259.765,264.248,271.047,275.996,278.417,282.9,287.849,294.744,299.693,306.131,312.013" y="250.476" svg_rhmargin="316.962" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ndings indicate that a high PVT1</text>
  <text x="71.887,75.805,80.754,85.704,89.156,93.074,96.526,99.978,102.399,107.348,112.297,115.879,118.3,122.218,126.701,130.619,133.04,136.628,139.049,142.501,146.095,150.014,154.963,158.415,161.867,165.785,168.206,172.689,175.576,179.495,184.44400000000002,188.047,194.951,197.372,200.259,205.208,208.796,213.745,218.695,223.644,227.096,230.679,238.049,242.532,244.953,248.537,255.441,260.391,264.874,267.295,270.873,277.311,282.26,286.743,289.164,292.756,298.172,305.542,314.508" y="261.41700000000003" svg_rhmargin="316.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">expression level is correlated with poor OS, DFS, RFS, LNM,</text>
  <text x="71.887,78.791,87.757,90.17800000000001,92.636,97.585,100.006,102.893,105.78,109.698,113.15,117.069,122.018,124.905,127.326,131.809,134.696,137.117,142.067,147.01600000000002,149.496,153.979,157.431,161.915,166.864,170.782,173.203,175.688,178.109,182.592,186.044,190.527,194.445,197.897,200.349,203.236,208.185,215.555,220.505,223.957,226.426,229.878,232.299,236.217,240.136,242.557,245.02,249.504,254.453,259.402,261.858,264.745,269.695,277.065,282.015,285.467,287.879,291.331,294.219,298.702,303.185,307.103,309.592,312.013" y="272.35900000000004" svg_rhmargin="316.962" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">DM, differentiation grade, larger tumor size, and tumor stage in</text>
  <text x="71.887,79.257,84.206,86.627,89.514,91.935,96.885,99.306,103.224,107.488,111.406,115.89,120.839,124.757,128.676,132.128,135.58,138.001,142.24,148.122,153.071,156.989,160.441,164.36,167.247,172.196,175.648,179.566,181.987,186.232,191.181,197.619,203.501,208.45000000000002,212.707,216.625,221.574,226.524,229.976,233.894,237.346,240.798,243.219,248.169,253.11800000000002,257.323,259.744,263.196,267.471,271.954,276.145,281.095,286.044,288.931,292.849,297.799,300.686,303.107,307.59,310.011,312.432" y="283.29999999999995" svg_rhmargin="316.915" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">multiple cancers. Therefore, PVT1 expression is a potentially</text>
  <text x="71.887,76.836,80.288,84.206,87.093,92.043,94.46400000000001,98.815,103.764,106.185,111.135,118.505,122.988,126.44,131.39,135.308,138.76,143.147,146.034,150.983,155.336,160.285,163.737,167.656,172.605,175.026,178.944,181.831,186.233,189.12,194.069,197.987,202.334,207.283,210.735,215.685,220.168,225.117,230.066,233.518,235.939,239.391,243.719,248.202,253.151,258.1,262.483,269.854,273.772,276.659,281.142,284.594,287.481,291.964,295.416,297.837,301.289,305.682,308.569,313.518" y="294.299" svg_rhmargin="316.97" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">useful biomarker to predict the prognosis and metastasis for</text>
  <text x="71.887,75.805,80.288,85.237,89.156,93.074,96.526,99.552,104.501,108.985,111.872,114.293,118.211,123.16,126.048,129.5" y="305.24" svg_rhmargin="131.921" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cancer patients.</text>
  <text x="71.887,78.483,84.399,88.043,93.958,99.675,103.612,106.752,112.27,117.987,123.902,127.546,131.483,134.237,140.153,146.068,149.712,152.466,158.183,164.098" y="331.887" svg_rhmargin="169.322" style="fill:#171615;font-family:NCNDPH+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">Author contributions</text>
  <text x="71.887,78.324,87.28999999999999,89.461,93.945,98.894,103.843,105.959,112.863,119.767,127.137,129.316,132.768,136.686,141.169,144.621,148.54,153.489,155.62,158.507,163.457,167.375,169.51,173.428,175.849,179.767,183.686,186.573,190.025,194.974,199.924,202.344,206.262,208.457,213.406,217.889,220.777,225.26,230.209,234.692,238.144,242.063,245.515,247.687,252.636,255.523,257.665,262.614,267.564,272.513,279.883,283.802,288.751,291.17199999999997,293.324,300.694,307.132,310.019" y="347.817" svg_rhmargin="316.923" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">CM and XGN search the electronic databases of Pubmed, OVID</text>
  <text x="71.887,76.37,81.319,86.268,88.667,97.633,101.552,106.501,108.906,113.855,116.742,119.167,123.65,127.568,129.989,133.907,138.857,142.775,146.693,149.114,151.537,157.975,166.941,169.339,173.822,178.771,183.72,186.176,192.614,198.03,206.996,209.363,213.282,217.765,222.248,224.669,229.618,234.101,236.988,240.907,245.85600000000002,248.31,252.793,255.214,257.635,260.045,264.995,267.882,270.306,273.194,278.143,282.061,284.479,286.9,291.85,295.768,298.189,303.138,308.088,312.006" y="358.815" svg_rhmargin="316.955" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and Web of Science. CM and YLW evaluated all of the included</text>
  <text x="71.887,75.339,78.226,83.175,88.125,90.545,94.464,97.916,102.16,106.643,111.592,116.541,120.811,124.729,129.679,132.566,136.018,140.501,144.419,147.307,151.225,156.174,160.439,163.326,168.275,172.193,176.426,181.375,185.858,188.745,193.228,197.515,199.936,204.886,209.835,213.753,218.703,222.621,227.57,232.52,236.438,241.387,244.274,246.695,251.179,253.6,257.891,264.329,273.295,277.506,281.989,286.939,291.88800000000003,296.158,303.062,308.011" y="369.757" svg_rhmargin="316.977" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">studies and extracted the data independently. CM and DPW</text>
  <text x="71.887,75.805,80.754,83.641,87.093,91.577,95.495,98.382,102.3,107.249,112.591,117.074,122.023,126.972,132.319,136.238,141.187,145.67,153.041,155.461,160.411,164.329,169.27800000000002,174.668,177.555,182.505,186.423,191.789,196.739,201.222,204.109,208.592,213.899,216.787,220.239,225.188,232.558,237.937,240.824,245.774,249.692,255.058,260.008,263.46,265.881,270.364,272.785,277.734,282.217,284.638,289.98,294.463,297.915,300.803,303.223,307.142,309.563,313.481" y="380.699" svg_rhmargin="316.933" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">extracted and examined the data from the original articles</text>
  <text x="71.887,74.307,79.257,84.206,88.125,93.074,96.992,101.942,106.891,110.809,115.759,118.646,121.067,125.55,127.971,130.619,137.989,144.893,150.308,152.955,156.407,160.326,163.778,168.727,171.148,175.631,179.549,184.49800000000002,187.084,189.971,194.92,198.838,201.484,206.433,208.854,212.306,216.789,221.272,224.724,228.643,232.561,239.931,243.849,248.799,251.686,255.138,257.778,260.199,265.148,267.755,270.643,275.592,279.51,282.155,284.576,286.997,289.884,293.803,297.255,301.738,304.625,309.574,313.026" y="391.697" svg_rhmargin="316.944" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">independently. QDL resolved the disagreements in the literature</text>
  <text x="71.887,76.37,79.822,83.274,87.192,90.644,94.096,101.466,105.385,110.334,113.221,117.863,122.346,127.296,132.245,136.855,143.292,152.258,156.867,163.771,168.255,171.707,176.313,180.796,185.384,192.754,197.237,199.658,204.608,208.06,212.652,216.57,221.52,226.469,229.356,232.808,235.229,240.179,245.128,248.015,252.965,256.41700000000003,261.067,263.487,268.43600000000004,273.029,279.933,283.385,285.806,288.693,291.114,296.063,300.546,305.173,308.06,313.009" y="402.638" svg_rhmargin="316.927" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">assessment and CM was a major contributor in writing the</text>
  <text svg_rhmargin="250.314" x="71.887,79.257,83.74,88.689,93.639,97.091,101.009,104.461,106.882,111.831,114.719,117.14,119.45,125.888,128.309,130.73,132.999,137.482,142.432,145.319,150.268,155.218,158.67,162.12199999999999,164.406,167.858,171.777,176.26,181.209,183.512,187.995,192.944,197.893,200.123,204.606,209.555,214.505,217.957,222.906,227.389,231.307,236.256,238.559,241.447,246.396,250.314" y="413.58" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">manuscript. All authors read and approved the </text>
  <text x="252.624" y="413.58" svg_rhmargin="257.573" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:8.97px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="257.556,262.506,266.989,269.40999999999997,271.673,279.043,283.526,288.476,293.425,296.877,300.795,304.247,306.668,311.618,314.505" y="413.58" svg_rhmargin="316.926" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">nal manuscript.</text>
  <text svg_rhmargin="128.087" x="71.887,78.791,83.274,86.161,90.644,93.656,97.574,102.524,105.976,110.459,113.346,115.767,120.716,125.666,128.087" y="424.522" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Data curation: </text>
  <text x="131.074,137.512,142.461,146.944,151.893,154.884,163.85,168.333,170.754,173.763,180.667,183.088,188.037,192.52,195.407,202.311,207.261,212.21,215.204,222.574,224.995,228.913,231.334,234.366,238.849,243.798,248.747,251.714,258.152,262.635,267.584,270.471,275.887,278.308,281.364,290.33,294.813,299.762,304.246" y="424.522" svg_rhmargin="306.667" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma, Xing-Guo Nie, and Yan-Li Wang.</text>
  <text svg_rhmargin="150.747" x="71.887,76.836,81.785,86.735,91.684,94.105,99.054,103.537,106.525,111.008,114.927,119.876,124.825,127.246,130.698,133.119,136.006,138.427,143.377,148.326,150.74699999999999" y="435.52" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Funding acquisition: </text>
  <text x="153.808,161.178,163.599,168.549,171.436,176.385,181.335,186.284,190.767,193.775,199.191,201.612,206.095,211.044,215.528" y="435.52" svg_rhmargin="217.949" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Qiu-dong Liang.</text>
  <text svg_rhmargin="123.479" x="71.887,74.774,79.723,84.206,88.125,91.577,94.464,96.885,101.368,105.851,108.738,111.159,116.108,121.058,123.47900000000001" y="446.461" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Investigation: </text>
  <text x="126.029,132.466,137.416,141.899,146.848,149.386,158.352,162.835,165.256,167.754,174.658,177.079,182.029,186.512,189.399,196.303,201.252,206.20100000000002,208.742,216.112,218.533,222.451,224.87199999999999,227.45,233.888,238.371,243.32,246.208,251.623,254.04399999999998,256.532,265.499,269.982,274.931,279.414,281.835,284.367,291.271,295.755,298.642,303.591,307.509,312.459" y="446.461" svg_rhmargin="316.942" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma, Xing-Guo Nie, Yan-Li Wang, Da-Peng</text>
  <text x="83.792,92.758,97.708,100.129,103.123,107.607,112.556,117.505,120.471,127.842,130.263,135.212,138.099,143.049,147.998,152.947,157.43,160.439,165.854,168.275,172.758,177.708,182.191" y="457.403" svg_rhmargin="184.612" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wu, and Qiu-dong Liang.</text>
  <text svg_rhmargin="126.213" x="71.887,80.853,84.771,87.658,92.608,97.557,102.506,107.456,109.877,114.826,119.309,123.792,126.21300000000001" y="468.401" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Methodology: </text>
  <text x="128.353,134.791,139.74,144.223,149.17200000000003,151.313,160.279,164.762,167.183,169.34,176.244,178.665,183.615,188.098,190.985,197.889,202.839,207.788,209.931,217.301,219.722,223.64,226.06099999999998,228.185,234.623,239.106,244.056,246.943,252.359,254.78,256.928,265.894,270.377,275.327,279.81,282.231,284.366,291.27,295.754,298.641,303.59,307.508,312.458" y="468.401" svg_rhmargin="316.941" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma, Xing-Guo Nie, Yan-Li Wang, Da-Peng</text>
  <text x="83.792,92.758,97.708,100.129,103.123,107.607,112.556,117.505,120.471,127.842,130.263,135.212,138.099,143.049,147.998,152.947,157.43,160.439,165.854,168.275,172.758,177.708,182.191" y="479.342" svg_rhmargin="184.612" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Wu, and Qiu-dong Liang.</text>
  <text svg_rhmargin="159.919" x="71.887,76.836,80.288,85.237,87.658,91.577,95.495,98.382,101.422,105.906,110.855,118.225,120.646,125.596,128.016,131.469,134.356,137.808,142.291,145.178,147.599,152.548,157.498,159.91899999999998" y="490.284" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Project administration: </text>
  <text x="162.936,169.374,174.323,178.806,183.75500000000002,186.746,195.712,200.195" y="490.284" svg_rhmargin="202.616" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma.</text>
  <text svg_rhmargin="108.272" x="71.887,76.37,81.319,84.206,87.093,93.997,98.481,101.933,105.851,108.272" y="501.282" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Software: </text>
  <text x="111.288,117.726,122.675,127.158,132.107,135.098,144.064,148.548,150.969,153.977,160.881,163.302,168.251,172.734,175.621,182.525,187.475,192.424,195.418,202.788,205.209,209.127,211.548,214.58,219.063,224.012,228.961,231.928,239.298,241.719,246.668,249.556,254.505,259.454,264.404,268.887,271.895,277.311,279.732,284.215,289.164,293.647" y="501.282" svg_rhmargin="296.068" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma, Xing-Guo Nie, and Qiu-dong Liang.</text>
  <text svg_rhmargin="118.736" x="71.887,76.37,81.319,86.269,90.187,93.639,98.122,100.543,103.995,106.416,111.365,116.315,118.736" y="512.2239999999999" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Supervision: </text>
  <text x="121.777,129.147,131.568,136.517,139.405,144.354,149.303,154.253,158.736,161.744,167.16,169.581,174.064,179.013,183.496" y="512.2239999999999" svg_rhmargin="185.917" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Qiu-dong Liang.</text>
  <text svg_rhmargin="101.466" x="71.887,80.853,84.305,86.726,89.613,92.034,96.983,101.46600000000001" y="523.165" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Writing </text>
  <text svg_rhmargin="108.968" x="104.485,108.968" y="523.165" style="fill:#171615;font-family:NDBKLP+AdvOT66af078c.B+20;font-size:8.97px;font-style:NORMAL;font-weight:normal;">– </text>
  <text svg_rhmargin="165.589" x="111.969,116.918,120.37,122.791,127.274,129.695,134.644,139.128,141.54899999999998,144.509,149.459,152.911,157.394,160.281,163.168,165.589" y="523.165" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">original draft: </text>
  <text x="168.605,175.043,179.992,184.476,189.425,192.415,201.381,205.865" y="523.165" svg_rhmargin="208.286" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Chao Ma.</text>
  <text svg_rhmargin="101.466" x="71.887,80.853,84.305,86.726,89.613,92.034,96.983,101.46600000000001" y="534.107" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Writing </text>
  <text svg_rhmargin="108.968" x="104.485,108.968" y="534.107" style="fill:#171615;font-family:NDBKLP+AdvOT66af078c.B+20;font-size:8.97px;font-style:NORMAL;font-weight:normal;">– </text>
  <text svg_rhmargin="179.876" x="111.969,115.421,119.339,123.822,126.243,130.161,137.065,140.03,148.431,151.426,155.344,160.293,162.714,165.601,168.022,172.972,177.455,179.876" y="534.107" style="fill:#171615;font-family:NDBKLO+AdvOT66af078c.B;font-size:8.97px;font-style:NORMAL;font-weight:normal;">review &amp; editing: </text>
  <text x="182.892,190.262,192.683,197.633,200.52,205.469,210.419,215.368,219.851,222.859,228.275,230.696,235.179,240.128,244.612" y="534.107" svg_rhmargin="247.033" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Qiu-dong Liang.</text>
  <text x="71.887,78.682,84.399,87.844,93.561,97.498,103.214,109.13,114.648,120.364" y="560.813" svg_rhmargin="125.588" style="fill:#171615;font-family:NCNDPH+AdvOTfbba3ace.B;font-size:9.46px;font-style:NORMAL;font-weight:normal;">References</text>
  <text x="76.195,78.601,82.726,85.132,88.44,92.176,94.193,97.459,101.194,104.46,106.47699999999999,108.168,113.533,118.046,120.063,121.773,129.245,131.262,133.28,135.297,138.562,141.43900000000002,143.145,148.51,154.263,156.28,157.997,160.874,164.139,170.281,174.017,176.034,177.782,183.147,185.164,186.852,192.217,195.953,200.077,203.342,206.607,209.484,211.171,214.048,216.454,220.19,222.595,224.613,227.49,229.895,231.913,235.178,238.055,240.072,241.839,245.964,250.088,254.212,258.337,260.354,262.076,267.441,272.806,274.492,279.856,283.592,287.717,290.982,294.247,297.124,298.811,301.688,303.403,308.768,310.786,312.803" y="575.213" svg_rhmargin="316.927" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin</text>
  <text x="88.441,92.566,96.691,100.816,104.942,106.96,111.085,115.21,117.228" y="584.227" svg_rhmargin="121.352" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;67:7</text>
  <text x="121.38" y="584.227" svg_rhmargin="125.116" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="125.121,129.247,133.372" y="584.227" svg_rhmargin="135.389" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">30.</text>
  <text x="76.196,78.602,82.726,85.132,88.441,91.317,95.442,99.566,103.691,106.567,109.444,113.568,117.693,119.903,124.028,126.045,128.18,132.693,134.711,138.835,142.96,146.695,148.713,151.978,156.103,158.339,162.852,164.869,167.012,172.765,175.642,179.378,183.502,187.627,190.892,193.769,195.979,201.733,203.75,205.957,209.222,211.62800000000001,213.78,217.515,219.533,221.54999999999998,223.757,228.27,232.005,236.13,238.147,242.272,244.678,246.695,250.819,254.944,258.68,261.556,265.292,267.52,270.785,274.909,279.034,281.91,285.176,288.052,291.788,295.524,297.93,299.947,304.072,308.197,310.432,314.557" y="593.184" svg_rhmargin="316.963" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[2] Johnsson P, Lipovich L, Grander D, et al. Evolutionary conservation of</text>
  <text x="88.442,90.459,94.583,98.708,102.444,104.655,108.779,112.904,117.028,119.434,122.699,126.823,130.948,132.965,137.09,140.826,143.033,148.398,154.539,159.904,162.781,164.798,167.069,169.945,173.211,177.335,181.46,184.725,188.849,192.114,195.379,197.396,199.608,202.484,204.89,207.767,211.891,215.157,217.563,221.687,224.564,227.829,229.846,232.09,234.496,238.62,242.745,246.01,248.416,250.513,254.638,258.762,260.779,262.985,267.499,269.516,273.641,276.906,281.03,283.048,289.19,291.387,295.9,297.917,302.042,306.166,310.29,314.026" y="602.141" svg_rhmargin="316.903" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">long non-coding RNAs; sequence, structure, function. Biochim Biophys</text>
  <text x="88.442,93.806,97.072,99.477,103.21300000000001,105.732,109.857,113.981,118.105,122.23,124.247,128.372,132.496,136.62,140.745,142.762,146.887,151.011,155.136" y="611.098" svg_rhmargin="159.26" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Acta 2014;1840:1063</text>
  <text x="159.307" y="611.098" svg_rhmargin="163.043" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="163.049,167.174,171.299" y="611.098" svg_rhmargin="173.316" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">71.</text>
  <text x="76.196,78.603,82.728,85.134,88.442,92.568,96.304,100.429,102.106,107.472,113.696,115.713,117.414,121.539,125.275,129.401,133.137,134.819,141.044,143.061,144.74,147.618,149.635,151.317,156.682,162.436,164.453,166.171,169.437,171.84300000000002,173.484,177.221,179.239,181.256,182.953,187.467,191.592,195.717,199.453,201.152,205.277,209.403,213.528,216.794,220.919,225.044,227.062,231.187,234.923,236.645,242.01,248.153,253.518,255.184,260.549,265.915,271.28,276.183,280.308,282.057,285.323,289.059,293.184,294.87,298.995,301.873,305.139,309.264,311.282,314.548" y="620.0550000000001" svg_rhmargin="316.954" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[3] Fan YH, Fang H, Ji CX, et al. Long noncoding RNA CCAT2 can predict</text>
  <text x="88.442,94.583,97.849,100.255,103.99,106.867,109.273,113.009,115.886,117.903,120.78,125.969,129.705,133.83,137.955,143.09,147.214,151.338,155.463,158.34,163.441,167.566,170.443,174.568,178.303,182.428,186.552,189.429,191.446,194.323,196.34,201.536,205.272,210.381,216.523,219.788,222.194,225.93,228.336,232.072,236.196,239.932,241.95,245.686,248.562,250.58,253.456,255.47299999999998,260.664,266.028,268.046,270.063,274.188,279.371,284.736,288.861,290.878,297.02,302.16,307.525,310.79,313.196" y="629.013" svg_rhmargin="316.932" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metastasis and poor prognosis: a meta-analysis. Clin Chim Acta</text>
  <text x="88.442,92.567,96.692,100.817,104.942,106.96,111.086,115.211,119.336,121.354,125.479,129.605" y="637.97" svg_rhmargin="133.729" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;466:120</text>
  <text x="133.795" y="637.97" svg_rhmargin="137.531" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="137.48,141.605" y="637.97" svg_rhmargin="143.622" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="76.196,78.602,82.726,85.132,88.441,92.955,94.972,96.492,101.394,103.411,104.996,110.362,114.486,117.751,121.876,123.478,128.842,130.859,132.378,137.743,141.867,145.603,149.728,153.464,155.053,157.93,159.947,161.516,164.781,167.187,168.772,172.508,174.526,176.543,178.07,182.583,186.707,189.972,195.337,201.479,206.84400000000002,208.454,213.356,218.721,224.474,228.599,230.166,234.29,237.167,241.291,247.433,251.558,253.964,257.319,260.196,261.741,265.006,268.271,270.289,272.306,275.183,276.764,280.888,283.765,287.889,289.907,291.924,294.33,297.595,300.472,304.208,306.614,308.631,312.755" y="646.984" svg_rhmargin="316.879" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[4] Li T, Chen Y, Zhang J, et al. LncRNA TUG1 promotes cells proliferation</text>
  <text x="88.442,92.177,96.302,100.427,104.032,106.049,110.173,114.298,116.39,120.514,122.532,124.938,127.815,131.469,134.735,138.0,140.017,142.035,144.912,148.59,152.325,156.45,160.574,164.699,167.105,171.229,174.106,176.123,179.0,182.66,185.065,189.19,192.066,196.191,200.315,204.051,208.176,211.854,214.731,217.996,221.732,225.856,227.874,231.61,234.015,236.033,240.157,243.893,247.568,252.933,258.297,263.662,269.11,274.475,278.124,280.141,284.266,287.874,291.14,295.264,297.281,299.687,303.812,307.077,309.189,311.207,314.942" y="655.941" svg_rhmargin="316.959" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and inhibits cells apoptosis through regulating AURKA in epithelial</text>
  <text x="88.442,92.566,96.302,100.038,102.914,104.932,108.668,112.793,115.312,118.577,122.313,126.437,129.702,132.968,135.845,138.384,141.649,144.914,146.932,148.949,151.826,153.843,156.354,163.826,167.091,171.216,173.233,176.498,178.516,182.64,185.90499999999997,188.44,190.846,195.359,199.094,201.112,203.518,205.535,211.677,215.801,218.678,221.943,224.34900000000002,226.931,231.055,235.18,239.304,243.428,245.446,249.57,253.695,255.712,258.977,263.102,267.226,271.43,275.555,279.679" y="664.898" svg_rhmargin="281.696" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ovarian cancer cells. Medicine (Baltimore) 2018;97:e12131.</text>
  <text x="76.196,78.603,82.728,85.134,88.442,93.808,97.933,102.058,106.183,109.419,114.785,116.80199999999999,120.078,127.551,131.287,135.412,139.148,142.359,148.113,152.627,154.644,157.893,162.019,165.755,169.88,173.61599999999999,176.887,183.029,185.046,188.282,192.796,196.921,201.046,204.78199999999998,208.069,212.194,216.319,220.444,223.71,227.836,231.961,233.979,238.104,241.84,245.092,250.458,256.6,261.96500000000003,265.218,268.955,273.08,278.446,283.811,288.01,290.417,292.824,297.726,301.851,305.076,307.093,309.97,313.24" y="673.855" svg_rhmargin="316.976" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[5] Zhou Y, Wang DL, Pang Q. Long noncoding RNA SPRY4-IT1 is a</text>
  <text x="88.442,92.566,95.443,99.567,103.303,107.427,111.552,114.429,116.834,118.852,122.117,124.268,126.674,130.41,133.675,136.081,140.205,143.08200000000002,145.186,147.592,151.717,154.59400000000002,156.751,160.875,165.0,169.124,172.001,174.098,178.223,181.959,185.224,188.1,191.836,193.854,195.871,198.021,200.897,205.022,207.899,211.634,213.652,217.388,221.124,223.141,225.288,229.024,233.148,237.273,239.403,243.528,247.264,250.14100000000002,252.215,255.951,260.076,262.193,266.318,270.442,273.707,277.832,281.567,284.833,288.957,290.974,294.239,296.376,299.252,303.377,305.394,308.659,310.775,312.792" y="682.813" svg_rhmargin="316.916" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">prognostic factor for poor overall survival and has an oncogenic role in</text>
  <text x="88.442,92.177,94.195,96.212,100.337,106.479,110.214,112.231,114.745,119.258,123.383,126.25999999999999,128.747,134.112,137.377,141.113,143.657,151.129,154.394,158.519,161.005,165.129,169.254,172.99,175.866,182.008,185.744,189.009,193.204,195.221,197.739,201.475,204.74,206.757,209.247,213.372,217.496,221.62,225.745,227.762,231.887,236.011,238.029,242.153,246.277,250.402" y="691.77" svg_rhmargin="254.526" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">glioma. Eur Rev Med Pharmacol Sci 2016;20:3035</text>
  <text x="254.608" y="691.77" svg_rhmargin="258.344" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="258.35,262.475" y="691.77" svg_rhmargin="264.492" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="76.196,78.603,82.728,85.134,88.442,93.808,97.933,101.199,105.324,109.06,111.064,116.429,118.446,120.419,126.173,129.909,134.034,136.01,141.376,143.393,145.365,149.878,151.89499999999998,153.869,159.623,161.64,163.621,166.886,169.292,171.274,175.011,177.029,179.046,181.026,185.54,189.665,193.79,197.52599999999998,199.509,203.634,207.76,211.885,214.291,217.557,221.682,225.808,227.826,231.951,235.68699999999998,237.724,243.089,249.232,254.597,256.603,262.745,268.111,272.236,276.361,280.875,285.0,286.991,291.116,293.994,298.119,304.262,308.387,310.793,314.059" y="700.784" svg_rhmargin="316.936" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[6] Zheng Y, Gao Y, Li X, et al. Long non-coding RNA NAP1L6 promotes</text>
  <text x="88.442,90.848,94.972,101.114,105.238,108.115,111.231,115.355,118.232,122.356,126.092,128.969,132.234,135.11,137.987,140.084,144.209,148.334,151.479,155.215,159.339,163.464,166.559,170.684,173.56,176.826,181.015,183.032,186.298,188.703,191.58,194.677,198.802,202.926,207.05,209.92700000000002,213.101,217.226,220.102,224.227,227.963,232.087,236.211,239.088,241.105,243.982,247.114,249.132,253.257,256.411,260.536,263.413,267.537,270.414,272.82,276.555,278.961,282.226,285.38,288.645,292.381,296.505,299.835,303.1,305.97700000000003,309.076,313.2" y="709.741" svg_rhmargin="316.936" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumor progression and predicts poor prognosis in prostate cancer by</text>
  <text x="88.442,90.848,94.583,97.46,101.196,104.461,106.867,108.884,113.009,116.745,119.28,121.686,125.81,129.935,131.952,136.077,138.094,142.218,144.624,148.749,152.014,154.42,158.15599999999998,160.719,166.084,168.101,170.584,176.725,180.85,184.189,188.314,190.766,195.668,199.404,202.28,206.016,209.282,211.687,214.56400000000002,217.126,222.028,226.152,229.417,232.294,234.813,238.938,243.062,247.187,251.311,253.329,257.453,261.577,263.595,267.719,271.844,275.968" y="718.698" svg_rhmargin="280.092" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">targeting Inhibin-beta A. Onco Targets Ther 2018;11:4965</text>
  <text x="280.119" y="718.698" svg_rhmargin="283.855" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="294.129" x="283.861,287.986,292.112,294.129" y="37.763000000000034" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">77. </text>
  <text x="336.189,338.594,342.719,345.125,348.433,353.798,357.534,361.659,366.404,372.158,374.175,378.876,384.242,387.978,392.103,396.791,402.156,404.173,408.923,414.287,418.412,422.148,426.272,430.008,434.716,439.229,441.246,445.941,449.206,451.612,456.316,460.051,462.069,464.086,468.788,473.3,477.425,480.69,486.055,492.197,497.562,502.347,506.86,513.002,516.738,521.639,525.764,529.888,534.013,538.137,542.262,546.961,551.085,553.962,558.086,564.228,568.352,570.758,574.114" y="37.763000000000034" svg_rhmargin="576.991" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[7] Yao X, Yan C, Zhang L, et al. LncRNA ENST00113 promotes</text>
  <text x="348.434,352.559,355.435,359.56,361.577,363.594,366.0,369.352,372.229,375.965,378.371,380.388,384.512,388.637,390.654,394.352,397.229,401.353,404.23,407.966,409.983,413.719,417.455,419.472,421.489,425.247,428.983,433.108,437.233,440.951,447.093,449.111,452.846,455.723,459.459,461.865,463.882,468.007,472.132,475.872,479.997,483.733,487.437,491.173,494.438,496.844,498.862,502.597,506.333,508.739,510.757,514.881,518.617,522.357,526.482,528.888,533.012,538.377,540.394,545.759,549.964,552.37,554.388,560.529,565.431,571.573" y="46.72000000000003" svg_rhmargin="576.938" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">proliferation, survival, and migration by activating PI3K/Akt/mTOR</text>
  <text x="348.434,351.311,353.328,357.064,361.188,364.924,366.942,368.959,373.084,376.82,380.747,384.871,388.607,391.013,395.137,400.891,404.627,408.363,412.209,414.226,418.351,422.187,425.923,428.329,432.453,435.718,438.595,442.719,445.596,448.943,450.961,454.226,457.102,461.227,464.104,466.121,468.998,471.015,474.906,482.378,485.643,489.768,491.785,495.05,497.068,501.192,504.457,508.295,510.701,515.214,518.95,520.968,523.374,525.391,531.533,535.657,538.534,541.911,544.3169999999999,548.147,552.272,556.396,560.521,564.645,566.662,570.787,574.911" y="55.67700000000002" svg_rhmargin="576.928" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">signaling pathway in atherosclerosis. Medicine (Baltimore) 2018;97:</text>
  <text x="348.434,351.699,355.824,359.948,364.073,368.197" y="64.63499999999999" svg_rhmargin="370.214" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">e0473.</text>
  <text x="336.189,338.594,342.719,345.125,348.433,355.905,359.64099999999996,361.302,366.667,368.68399999999997,370.315,376.539,380.664,384.4,388.524,392.26,393.954,400.178,402.195,403.819,409.572,413.697,415.327,420.692,422.709,424.397,427.662,430.068,431.71,435.446,437.464,439.481,441.121,446.486,450.61,453.487,456.363,459.629,463.753,466.159,467.821,471.557,475.681,479.417,483.153,487.277,490.61,493.875,496.752,498.377,502.501,504.907,506.54,508.558,512.682,516.807,520.543,522.243,526.367,530.492,534.616,537.022,540.287,544.412,548.536,550.554,554.678,558.414,560.054,565.419,571.561" y="73.59199999999998" svg_rhmargin="576.926" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[8] Ma Z, Huang H, Xu Y, et al. Current advances of long non-coding RNA</text>
  <text x="348.434,352.559,354.576,358.312,362.436,364.454,368.19,370.259,374.384,378.508,381.385,384.715,388.451,392.575,394.593,398.329,400.734,404.0,408.125,410.168,412.186,416.311,418.389,420.406,422.424,426.159,429.425,432.302,434.375,437.64,441.376,445.5,448.765,452.031,454.908,456.993,459.011,463.136,465.214,469.338,473.463,479.604,483.34,487.465,489.533,491.939,496.063,502.205,506.329,509.206,512.083,514.1,516.177,522.318,526.443,529.708,533.833,535.904,540.807,544.543,547.419,551.155,554.42,556.826,559.703,561.811,566.713,570.837,574.103" y="82.54899999999998" svg_rhmargin="576.98" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">highly upregulated in liver cancer in human tumors. Onco Targets Ther</text>
  <text x="348.434,352.559,356.684,360.81,364.935,366.953,371.078,375.203,377.293,381.418,385.543,389.668" y="91.56299999999999" svg_rhmargin="393.792" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;10:4711</text>
  <text x="393.788" y="91.56299999999999" svg_rhmargin="397.524" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.53,401.654" y="91.56299999999999" svg_rhmargin="403.671" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="336.189,338.595,342.72,345.12600000000003,348.435,352.56,356.297,360.422,363.686,369.051,371.068,374.344,379.71,383.446,387.571,390.843,395.745,397.762,401.048,406.413,410.538,414.275,416.292,419.587,424.953,426.96999999999997,430.246,433.512,435.918,439.204,442.94,444.959,446.976,450.26,454.774,458.899,463.024,466.76,469.99,474.115,478.24,482.365,485.695,489.82,493.945,495.963,500.089,503.825,507.069,512.435,518.577,523.942,527.252,533.477,539.62,544.522,549.424,551.831,555.956,559.228,562.965,565.842,569.15,572.887" y="100.51999999999998" svg_rhmargin="577.011" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[9] Fan Y, Yan T, Chai Y, et al. Long noncoding RNA HOTTIP as an</text>
  <text x="348.434,350.452,354.576,358.7,361.966,366.09,369.355,373.48,377.685,380.951,385.075,387.481,392.425,396.549,399.426,403.551,407.286,411.411,415.535,418.412,420.818,422.835,426.09999999999997,431.03,437.171,440.907,443.784,447.979,451.244,454.12100000000004,459.034,461.051,465.176,470.088,473.354,477.089,481.214,484.544,487.809,490.686,492.703,497.639,503.004,505.021,507.039,511.164,516.12,521.485,525.609,527.626,533.768,538.682,544.048,547.313,549.795,553.531,558.412,562.536,566.661,570.785,574.91" y="109.47799999999995" svg_rhmargin="576.927" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">independent prognostic marker in cancer. Clin Chim Acta 2018;</text>
  <text x="348.434,352.559,356.683,360.807,362.825,366.949,371.074" y="118.43499999999995" svg_rhmargin="375.198" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">482:224</text>
  <text x="375.25" y="118.43499999999995" svg_rhmargin="378.986" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="378.992,383.117,387.242" y="118.43499999999995" svg_rhmargin="389.259" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">30.</text>
  <text x="332.05,334.456,338.58,342.705,345.111,348.433,354.187,358.312,361.529,366.894,368.911,372.073,376.198,379.463,381.48,384.658,389.56,391.577,394.749,400.114,403.379,406.255,410.452,414.187,417.923,422.048,425.191,430.556,436.309,438.326,441.575,444.84,447.246,450.418,454.154,456.171,458.188,461.359,463.765,467.889,470.295,473.561,477.296,480.173,483.909,486.315,488.332,492.068,495.33299999999997,498.547,502.283,505.548,509.672,513.797,519.939,521.956,525.221,528.478,532.214,536.339,540.075,542.092,545.828,548.705,551.97,554.847,558.07,560.946,564.212,567.947,571.213,574.949" y="127.39200000000005" svg_rhmargin="576.966" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[10] Du Z, Fei T, Verhaak RG, et al. Integrative genomic analyses reveal</text>
  <text x="348.434,351.699,353.717,355.734,359.859,361.876,365.141,368.877,370.894,372.912,376.64799999999997,379.5,382.376,385.641,387.659,390.924,394.66,398.396,402.52,404.926,407.73,409.748,413.872,417.997,421.733,424.567,428.692,432.817,436.941,440.206,444.331,448.455,450.473,454.597,458.33299999999997,461.132,466.497,472.639,478.003,480.88,483.694,485.711,489.836,492.594,496.719,500.843,507.05,510.786,514.9110000000001,517.651,520.916,524.652,528.776,532.107,535.372,538.248,540.2650000000001,543.048,549.189,552.925,555.3309999999999,558.127,561.863,564.269,567.146,571.27,574.535" y="136.34900000000005" svg_rhmargin="576.941" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">clinically relevant long noncoding RNAs in human cancer. Nat Struct</text>
  <text x="348.434,355.906,360.03,362.04699999999997,364.59,369.103,371.121,375.245,377.262,379.783,383.907,388.032,392.156,396.281,398.298,402.422,406.547,408.564,412.689,416.813" y="145.36300000000006" svg_rhmargin="420.937" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Mol Biol 2013;20:908</text>
  <text x="421.001" y="145.36300000000006" svg_rhmargin="424.737" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="424.743,428.868,432.993" y="145.36300000000006" svg_rhmargin="435.01" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">13.</text>
  <text x="332.051,334.457,338.581,342.705,345.111,348.434,353.336,357.072,361.196,364.932,369.056,372.792,375.669,379.793,381.81,384.488,389.853,391.87,394.466,398.202,401.937,407.691,411.427,415.551,419.287,421.903,427.657,429.674,432.277,437.642,441.767,444.643,448.379,451.324,455.449,457.466,461.202,464.467,467.084,469.961,471.978,474.567,477.832,480.238,482.844,486.579,488.597,490.614,493.217,498.582,504.724,508.848,510.866" y="154.32000000000005" svg_rhmargin="512.883" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[11] Takahashi Y, Sawada G, Kurashige J, et al. Ampli</text>
  <text x="512.957" y="154.32000000000005" svg_rhmargin="517.081" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="517.096,520.361,524.097,526.503,528.52,532.645,536.77,539.375,543.499,545.905,548.501,552.626,557.991,562.957,565.363,569.488,572.085,574.102" y="154.32000000000005" svg_rhmargin="576.979" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cation of PVT-1 is</text>
  <text x="348.436,350.453,354.577,358.313,362.438,364.455,368.191,371.456,375.581,377.29,379.308,383.433,385.114,389.238,393.363,397.487,400.36400000000003,402.064,406.188,409.065,413.189,416.925,421.111,425.235,428.112,430.129,433.00600000000003,434.659,438.395,440.413,444.149,445.884,449.62,453.745,457.869,461.993,464.399,468.524,471.4,473.418,476.295,478.026,480.044,484.168,488.293,490.31,494.434,496.452,498.858,500.875,505.0,509.125,510.849,512.867,516.992,518.673,521.938,526.063,528.08,532.204,535.081,538.346,541.611,544.017,547.753,549.7700000000001,551.495,554.76,558.496,562.621,565.886,569.151,572.028,574.904" y="163.27800000000002" svg_rhmargin="576.921" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">involved in poor prognosis via apoptosis inhibition in colorectal cancers.</text>
  <text x="348.436,352.949,355.826,358.357,361.23400000000004,363.742,369.108,372.844,376.968,380.233,383.498,386.375,388.856,392.98,397.105,401.229,405.353,407.371,411.495,415.62,419.744,421.848,425.973,430.097" y="172.235" svg_rhmargin="434.221" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Br J Cancer 2014;110:164</text>
  <text x="434.211" y="172.235" svg_rhmargin="437.947" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="437.953,442.078,446.203" y="172.235" svg_rhmargin="448.22" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">71.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,353.8,357.535,360.412,363.289,367.025,373.167,377.291,380.168,383.904,386.246,390.759,392.776,395.033,400.397,404.522,408.646,411.052,413.07,417.194,421.319,423.603,427.728,429.745,432.051,436.175,439.441,442.317,445.194,449.319,451.552,456.917,458.93399999999997,461.246,464.511,466.91700000000003,469.183,472.919,474.936,476.953,479.217,484.118,488.243,491.508,493.786,497.91,503.275,508.177,510.582,514.707,517.028,521.153,525.277,528.542,532.667,536.403,539.668,543.792,547.057,549.341,551.358,554.2349999999999,556.484,560.22,562.494,569.966,573.702" y="181.192" svg_rhmargin="576.967" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[12] Carramusa L, Contino F, Ferro A, et al. The PVT-1 oncogene is a Myc</text>
  <text x="348.436,352.56,355.437,359.561,361.967,365.232,367.25,371.375,373.946,376.352,380.088,382.964,386.7,389.965,392.371,394.977,397.383,401.508,405.244,407.65000000000003,410.17,412.187,415.064,417.596,421.72,425.456,428.722,431.598,434.863,438.988,443.112,445.989,449.341,452.218,455.095,458.36,462.485,464.987,467.005,471.13,473.718,476.124,479.001,482.737,486.861,489.738,492.144,496.268,499.145,505.286,508.552,512.677,515.27,518.536,521.801,523.818,525.836,528.712,530.729,533.298,536.175,538.683,544.049,547.314,549.331,551.3480000000001,553.933,558.058,562.182,565.918,568.795,570.812,574.937" y="190.149" svg_rhmargin="576.954" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">protein target that is overexpressed in transformed cells. J Cell Physiol</text>
  <text x="348.436,352.56,356.684,360.809,364.933,366.951,371.075,375.2,379.324,381.428,385.552,389.677" y="199.106" svg_rhmargin="393.801" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2007;213:511</text>
  <text x="393.789" y="199.106" svg_rhmargin="397.525" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.531,401.656" y="199.106" svg_rhmargin="403.673" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,352.948,354.965,359.09,361.7,366.214,368.231,370.828,375.342,377.359,381.484,384.094,389.459,391.476,394.128,399.493,403.617,407.741,411.866,414.48,419.845,421.862,424.457,427.723,430.129,432.734,436.47,438.487,440.504,443.108,449.25,452.986,456.251,459.128,462.393,466.518,470.715,473.592,476.857,479.734,482.61,484.628,488.752,492.877,495.488,499.612,502.01800000000003,504.615,506.632,510.757,514.881,518.617,521.225,525.35,529.474,533.599,536.078,539.343,543.467,547.592,549.609,553.734,557.47,560.057,565.422,571.564" y="208.12" svg_rhmargin="576.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[13] Liu E, Liu Z, Zhou Y, et al. Overexpression of long non-coding RNA</text>
  <text x="348.436,352.56,357.925,362.826,366.951,369.014,371.031,375.156,377.177,381.302,385.038,388.774,391.65,393.668,397.404,401.529,403.538,406.803,410.539,414.663,417.928,421.194,424.071,426.1,429.365,432.63,434.647,436.665,439.54200000000003,441.576,445.7,448.577,452.701,458.843,462.968,465.374,468.729,471.606,473.605,476.87,478.887,481.764,485.888,487.906,491.642,494.047,496.065,500.19,502.232,505.109,508.374,511.25,513.268,516.145,518.55,522.286,526.411,529.676,532.941,534.998,539.123,542.859,544.863,547.739,551.004,554.74,558.865,560.882,564.618,567.024,569.125,573.25" y="217.07799999999997" svg_rhmargin="576.986" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating</text>
  <text x="348.436,352.172,356.296,360.42,364.545,366.951,371.075,373.481,375.498,378.763,381.314,385.439,389.175,391.581,395.705,401.458,405.194,408.93,411.807,413.824,416.404,418.81,422.935,425.341,427.799,430.676,433.184,438.549,440.567,442.584,446.709,449.228,453.741,457.865,461.99,464.534,472.006,475.271,479.396,481.88,486.005,490.129,494.254,498.378,500.395,504.52,506.537,510.662,514.786,518.911,523.035" y="226.03499999999997" svg_rhmargin="527.159" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">apoptotic pathways. Int J Clin Exp Med 2015;8:20565</text>
  <text x="527.244" y="226.03499999999997" svg_rhmargin="530.98" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="530.986,535.111,539.236" y="226.03499999999997" svg_rhmargin="541.253" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">72.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,353.8,357.924,361.66,365.784,369.52,371.507,377.26,384.732,386.749,388.684,393.197,397.322,399.285,403.409,405.426,407.335,411.848,413.865,417.99,419.977,424.49,426.507,428.424,431.689,434.095,436.078,439.813,441.831,443.848,445.771,451.913,455.649,458.914,461.791,465.056,469.181,473.378,476.255,479.52,482.397,485.273,487.291,491.415,495.54,497.471,501.596,504.002,505.975,507.993,512.117,516.242,519.978,521.905,526.03,530.155,534.279,536.685,539.951,544.075,548.199,550.217,554.341,558.077,560.057,565.422,571.564" y="234.99199999999996" svg_rhmargin="576.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[14] Zhang XW, Bu P, Liu L, et al. Overexpression of long non-coding RNA</text>
  <text x="348.436,352.56,357.925,362.826,366.951,370.317,372.335,376.46,379.842,383.578,387.314,390.19,392.596,395.473,397.49,400.755,404.161,407.426,411.162,415.286,418.552,421.817,424.694,428.083,431.349,434.614,436.631,438.649,441.526,444.92,449.045,451.921,456.046,462.188,466.312,468.718,471.983,474.86,478.253,480.659,484.783,488.048,491.405,495.529,498.794,502.53,505.86,507.878,512.002,516.127,522.268,525.534,529.658,532.064,535.452,539.576,541.982,545.373,551.515,555.639,557.656,560.062,562.08,566.204,569.081,573.205" y="243.94899999999996" svg_rhmargin="576.941" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 in gastric cancer cells promotes the development of multidrug</text>
  <text x="348.436,351.312,354.577,357.454,359.471,362.348,364.754,368.49,372.698,375.963,379.228,381.245,383.753,388.266,390.283,394.407,397.672,401.797,405.062,411.204,413.741,418.254,420.271,424.395,428.52,432.644,436.38,439.257,441.745,447.11,450.375,453.252,455.804,461.169,465.294,471.435,477.577,481.702,485.827,488.343,492.468,496.592,500.717,504.841,506.858,510.983,515.107,519.232,521.249,525.374,529.498" y="252.90599999999995" svg_rhmargin="533.622" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">resistance. Biochem Biophys Res Commun 2015;462:227</text>
  <text x="533.707" y="252.90599999999995" svg_rhmargin="537.443" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="537.449,541.574,545.699" y="252.90599999999995" svg_rhmargin="547.716" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="332.051,334.457,338.582,342.706,345.112,348.435,352.559,356.295,360.42,361.983,367.348,373.572,375.589,377.176,380.052,382.069,383.695,389.06,394.813,396.83,398.377,404.13,408.255,409.828,414.341,416.358,417.935,421.2,423.606,425.192,428.928,430.945,432.962,434.546,439.059,443.183,447.308,451.044,452.63,456.754,460.879,465.003,468.268,472.393,476.517,478.534,482.731,486.467,488.003,493.368,499.51,504.875,506.484,510.22,513.485,515.891,517.909,521.645,525.38,527.786,531.052,535.177,536.756,540.88,544.616,546.223,551.125,556.878,561.002,563.408,567.533,570.798,573.204" y="261.91999999999996" svg_rhmargin="576.94" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[15] Fan YH, Ji CX, Xu B, et al. Long noncoding RNA activated by TGF-beta</text>
  <text x="348.436,350.453,354.578,357.11,361.234,365.358,371.5,375.236,379.361,381.882,385.147,388.883,393.008,396.273,399.538,402.415,405.291,407.308,409.83,413.566,416.066,422.208,425.474,427.879,431.615,434.021,437.757,441.882,445.617,447.635,451.371,454.247,456.265,459.141,461.158,463.741,469.106,471.123,473.141,477.266,479.785,485.149,489.274,491.291,497.433,499.966,505.331,508.596,511.002,514.738,517.256,521.381,525.505,529.63,533.754,535.771,539.896,544.02,548.145,550.162,554.287" y="270.87800000000004" svg_rhmargin="558.411" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in human cancers: a meta-analysis. Clin Chim Acta 2017;468:10</text>
  <text x="558.482" y="270.87800000000004" svg_rhmargin="562.218" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="562.224,566.349" y="270.87800000000004" svg_rhmargin="568.366" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,355.818,358.224,364.365,368.101,372.226,374.966,380.719,386.472,388.489,391.179,398.651,401.916,405.652,409.776,413.512,417.636,420.901,423.604,428.117,435.589,437.606,440.327,444.063,447.799,451.924,455.189,458.066,462.19,465.067,468.332,470.349,473.037,480.509,482.526,485.225,488.49,490.896,493.558,497.294,499.311,501.328,504.045,509.41,512.675,516.8,520.924,523.801,526.207,528.224,532.349,536.085,538.795,544.161,547.426,550.691,554.816,560.958,567.099,570.365,574.489" y="279.83500000000004" svg_rhmargin="576.895" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[16] Altman DG, McShane LM, Sauerbrei W, et al. Reporting Recommen-</text>
  <text x="348.436,352.561,356.297,358.703,360.72,364.844,368.969,371.846,374.003,376.409,380.533,383.41,385.454,390.355,394.48,400.622,404.746,407.623,409.773,417.245,420.981,423.857,427.982,431.247,434.124,436.19,440.314,443.191,447.315,451.051,455.237,459.362,462.238,464.644,466.662,469.92699999999996,472.018,475.753,478.159,482.284,486.408,488.426,491.691,494.568,496.677,499.083,504.447,508.96,516.432,521.797,527.162,532.617,535.023,537.0400000000001,539.136,542.401,546.526,550.65,552.667,556.403,560.528,564.264,566.67,568.687,572.811" y="288.792" svg_rhmargin="576.935" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">dations for Tumor Marker Prognostic Studies (REMARK): explanation</text>
  <text x="348.436,352.172,356.297,360.422,362.949,366.214,368.231,371.967,376.092,380.216,383.093,386.829,389.235,391.252,395.376,399.501,401.518,404.047,408.172,412.685,416.809,420.545,423.095,430.567,433.832,437.957,440.443,444.567,448.691,452.816,456.94,458.958,463.082,465.099,468.365,472.489,476.613,480.738,484.942,489.067,493.191,497.315" y="297.749" svg_rhmargin="499.332" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and elaboration. PLoS Med 2012;9:e1001216.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,361.661,365.785,369.521,371.168,375.681,377.698,379.275,383.789,385.806,387.439,393.193,395.21,396.794,402.159,405.895,410.02,411.647,417.871,419.888,421.454,424.72,427.12600000000003,428.768,432.504,434.521,436.538,438.122,441.858,445.594,447.611,449.628,453.364,457.169,460.046,463.782,465.333,471.474,475.21,477.691,480.568,482.585,486.71,488.292,494.434,497.699,500.105,503.841,505.858,507.876,512.0,516.124,519.001,523.125,525.531,528.797,530.921,535.045,538.781,541.658,544.923,546.51,548.916,556.388,563.86,567.984,570.39,572.796" y="306.706" svg_rhmargin="576.92" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[17] Zhang L, Li X, Yan H, et al. Salivary matrix metalloproteinase (MMP)-8</text>
  <text x="348.436,352.172,355.04900000000004,356.6,360.336,361.872,365.997,368.015,372.139,378.281,382.017,384.893,389.018,392.371,395.248,396.793,399.199,403.323,406.2,407.734,411.859,415.124,418.001,420.018,424.143,428.267,432.392,436.589,438.995,441.013,443.418,445.436,448.313,450.33,451.895,455.631,457.167,461.292,466.657,469.062,472.87,480.342,485.707,488.113,491.378,495.502,501.644,505.768,507.786,509.803,513.539,517.663,520.069,521.678,524.555,528.291,531.167,533.573,536.838,542.98,546.716,549.122,551.14,554.405,556.031,558.908,562.173,565.909,567.926,571.192" y="315.664" svg_rhmargin="576.945" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">as a biomarker for periodontitis: a PRISMA-compliant systematic review</text>
  <text x="348.436,352.172,356.297,360.422,362.949,369.091,372.357,374.762,378.498,380.904,384.64,388.765,392.5,394.518,398.254,401.13,403.148,406.024,408.041,410.624,418.096,421.361,425.486,427.503,430.768,432.785,436.91,440.175,442.709,445.115,449.628,453.364,455.382,457.788,459.805,465.947,470.071,472.948,476.213,478.619,481.2,485.325,489.449,493.574,497.698,499.716,503.84,507.964,509.982,513.247,517.371,521.496,525.62,529.745" y="324.678" svg_rhmargin="531.762" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and meta-analysis. Medicine (Baltimore) 2018;97:e9642.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,362.049,366.174,369.90999999999997,373.379,378.744,380.761,384.208,389.572,393.697,396.962,401.087,404.559,409.925,411.942,415.331,421.085,425.209,429.334,432.791,436.527,438.544,441.975,445.24,447.646,451.102,454.838,456.856,458.873,462.327,467.229,472.594,478.347,482.471,484.488,487.95,491.686,495.811,501.175,506.54,510.665,513.071,515.477,520.378,524.502,526.519,530.013,533.749,537.873,541.998,545.432,551.656,557.021,561.534,566.899,570.376,574.111" y="333.635" svg_rhmargin="576.988" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[18] Zhong Y, Chen Z, Guo S, et al. TUG1, SPRY4-IT1, and HULC as</text>
  <text x="348.436,352.172,355.908,357.926,362.05,365.786,369.978,371.996,375.26099999999997,379.843,383.967,386.844,390.968,394.704,398.828,402.953,405.829,408.235,410.253,413.518,418.164,422.288,424.306,428.43,434.572,438.308,441.184,445.309,448.574,451.451,454.32800000000003,458.923,463.047,465.45300000000003,470.091,472.967,477.092,479.968,483.704,485.722,489.458,493.193,495.21,499.796,501.813,505.938,510.567,513.832,517.568,521.692,524.958,528.223,531.099,533.1160000000001,537.721,541.457,546.055,550.179,555.544,557.95,561.686,569.158,574.523" y="342.592" svg_rhmargin="576.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">valuable prognostic biomarkers of survival in cancer: a PRISMA-</text>
  <text x="348.436,351.702,355.826,361.968,366.092,368.11,370.127,373.946,378.07,380.476,382.96,389.102,392.367,394.773,398.509,400.914,404.65,408.775,412.511,414.528,418.264,421.141,423.158,426.035,428.052,430.634,438.106,441.371,445.496,447.513,450.778,452.796,456.92,460.185,462.72,465.126,469.639,473.374,475.392,477.798,479.815,485.957,490.081,492.958,496.223,498.629,501.211,505.335,509.46,513.584,517.708,519.726,523.85,527.975,529.992,533.257,537.382,541.506,545.711,549.835" y="351.549" svg_rhmargin="551.852" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">compliant meta-analysis. Medicine (Baltimore) 2017;96:e8583.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,361.19,365.315,367.03,369.907,371.924,373.606,378.119,380.136,381.826,387.19,389.207,390.896,396.26,400.385,403.65,407.774,411.51,413.231,419.373,421.39,423.095,426.36,428.766,430.465,434.201,436.218,438.235,439.931,445.296,447.314,450.19,453.455,457.58,459.597,463.333,466.21000000000004,467.936,473.301,479.442,484.807,486.473,490.598,493.474" y="360.506" svg_rhmargin="497.598" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[19] Chen J, Li Y, Zheng Q, et al. Circular RNA pro</text>
  <text x="497.651" y="360.506" svg_rhmargin="501.775" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="501.79,503.807,507.072,508.763,510.78,514.904,518.17,522.294,524.7" y="360.506" svg_rhmargin="526.717" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le identi</text>
  <text x="526.734" y="360.506" svg_rhmargin="530.858" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="530.873,534.138,537.015,538.696,541.961,543.979,546.855,550.12,554.245,559.61,564.511,568.636,570.385,574.121" y="360.506" svg_rhmargin="576.998" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">es circPVT1 as</text>
  <text x="348.436,352.17199999999997,355.069,359.193,362.07,366.195,368.212,370.229,372.635,375.9,378.777,382.513,384.919,386.936,390.672,393.937,396.905,399.311,403.047,406.312,408.718,412.842,415.719,418.617,422.353,426.477,430.602,433.469,437.594,440.47,444.595,448.33,452.455,456.579,459.456,461.862,463.879,467.144,470.09,476.232,479.968,482.844,486.969,490.234,493.111,495.997,498.014,502.139,505.011,508.747,512.483,515.359,517.765,520.642,522.659,525.924,528.82,532.085,535.821,539.945,543.275,546.541,549.417,551.4340000000001,554.33,559.695,563.431,567.555,570.82,574.086" y="369.464" svg_rhmargin="576.963" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a proliferative factor and prognostic marker in gastric cancer. Cancer</text>
  <text x="348.436,352.949,356.214,358.62,361.026,363.572,367.696,371.821,375.945,380.07,382.087,386.211,390.336,394.46,396.478,400.602,404.727" y="378.478" svg_rhmargin="408.851" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Lett 2017;388:208</text>
  <text x="408.927" y="378.478" svg_rhmargin="412.663" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="412.669,416.794,420.92" y="378.478" svg_rhmargin="422.937" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">19.</text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.925,359.942,362.608,368.362,370.379,372.983,378.348,382.473,385.115,390.48,396.704,398.721,401.385,405.898,407.916,412.041,414.651,422.123,424.14,426.783,430.048,432.454,435.059,438.795,440.812,442.829,445.49,450.003,454.127,458.252,461.988,464.594,468.718,472.842,476.967,479.373,482.638,486.762,490.887,492.904,497.029,500.765,503.425,508.79,514.932,520.297,522.927,527.051,532.416,537.382,541.507,544.072,547.808,550.685,553.312,557.048,559.662,563.786,567.911,571.646,574.912" y="387.435" svg_rhmargin="576.929" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[20] Cui D, Yu CH, Liu M, et al. Long non-coding RNA PVT1 as a novel</text>
  <text x="348.436,352.561,354.578,358.703,364.844,368.58,371.457,375.581,378.935,381.812,384.887,387.293,391.418,394.295,397.416,401.541,403.558,407.294,411.03,415.154,419.279,422.155,424.173,427.05,430.182,433.918,438.043,442.168,445.262,449.386,452.263,456.387,460.123,464.248,468.372,471.249,473.266,476.14300000000003,479.275,483.399,485.805,488.855,492.98,497.104,501.228,503.708,506.584,512.726,516.462,518.479,520.4960000000001,523.605,526.87,530.135,532.153,534.1700000000001,537.267,539.285,543.409,547.534,551.27,554.387,557.653,561.389,565.513,568.778,572.043,574.92" y="396.392" svg_rhmargin="576.937" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">biomarker for diagnosis and prognosis of non-small cell lung cancer.</text>
  <text x="348.436,353.338,357.462,363.604,367.728,371.853,374.73,377.291,381.805,383.822,387.946,389.963,392.484,396.608,400.733,404.857,408.982,410.999,415.124,419.248,421.265,425.39,429.514,433.639" y="405.349" svg_rhmargin="437.763" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Tumour Biol 2016;37:4127</text>
  <text x="437.784" y="405.349" svg_rhmargin="441.52" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="441.526,445.651,449.776" y="405.349" svg_rhmargin="451.793" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,353.801,357.925,359.942,361.475,366.84,368.85699999999997,370.432,374.946,376.964,381.089,382.621,387.134,389.151,390.671,396.036,400.161,403.426,407.551,409.095,411.972,413.989,415.502,418.767,421.173,422.701,426.437,428.455,430.472,431.999,434.405,438.529,441.794,444.671,447.936,451.672,454.548,457.814,461.939,463.518,466.783,470.907,475.032,477.908,481.173,484.05,486.927,488.944,493.069,497.194,498.721,502.845,505.25100000000003,506.828,508.845,512.97,517.094,520.83,522.361,526.485,530.61,534.734,537.14,540.405,544.53,548.654,550.672,554.796,558.532,560.059,565.423,571.565" y="414.306" svg_rhmargin="576.93" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[21] Cui Y, Liu L, Chen J, et al. Increased expression of long non-coding RNA</text>
  <text x="348.437,352.561,357.926,362.828,366.953,368.845,372.11,376.234,379.111,381.988,385.253,387.27,391.006,393.412,396.677,399.55400000000003,401.44,407.194,409.211,411.617,415.742,417.654,420.919,422.936,424.953,429.078,431.095,434.36,438.096,440.113,442.03,446.154,449.031,453.155,456.891,459.768,463.033,465.909,468.786,470.803,474.928,479.053,480.917,484.653,488.778,492.903,494.75,498.874,502.999,507.123,510.0,511.87,515.994,518.871,522.995,526.731,530.917,535.041,537.918,539.935,542.8119999999999,544.693,546.71,550.835,552.686,556.811,558.828,562.564,566.688,570.813,574.078" y="423.263" svg_rhmargin="576.955" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 correlates with clinical progression and poor prognosis in bladder</text>
  <text x="348.437,351.702,355.438,359.563,362.828,366.093,368.97,370.987,373.55,375.956,380.08,382.486,385.001,387.878,390.33,395.695,397.713,399.73,403.855,406.43,410.943,415.068,419.193,421.679,425.804,429.54,431.946,436.071,440.195,442.212,444.752,448.877,453.001,457.125,461.25,463.267,467.392,471.516,473.534,477.658,481.782,485.907" y="432.221" svg_rhmargin="490.031" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer. Int J Clin Exp Pathol 2017;10:3265</text>
  <text x="490.055" y="432.221" svg_rhmargin="493.791" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="493.797,497.922,502.048" y="432.221" svg_rhmargin="504.065" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">71.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,354.19,356.207,360.331,364.067,366.464,369.34,371.35699999999997,373.72,378.233,380.25,382.564,388.317,390.334,392.711,398.465,402.589,406.713,410.449,412.836,420.308,422.325,424.684,427.949,430.355,432.677,436.413,438.43,440.447,442.825,447.338,451.462,455.586,458.463,461.728,464.605,467.482,469.499,473.623,477.748,480.125,483.861,487.986,492.111,494.468,497.733,499.751,501.768,505.892,507.91,511.175,514.911,516.928,519.298,522.174,524.192,527.928,532.052" y="441.235" svg_rhmargin="534.069" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[22] Ding J, Li D, Gong M, et al. Expression and clinical signi</text>
  <text x="534.162" y="441.235" svg_rhmargin="538.286" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="538.244,541.509,545.245,549.37,552.7,555.965,558.313,562.437,564.843,567.156,569.562,573.687" y="441.235" svg_rhmargin="576.952" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance of the</text>
  <text x="348.437,350.454,354.579,358.703,362.43899999999996,363.913,368.039,372.163,376.287,378.693,381.958,386.083,390.207,392.225,396.349,400.085,401.555,406.919,413.061,418.426,419.865,423.99,429.354,434.256,438.381,439.819,441.837,445.962,447.359,451.483,455.608,461.75,465.486,469.611,471.055,474.791,478.527,481.403,483.809,486.686,488.703,491.96799999999996,493.447,496.712,500.448,504.573,507.838,511.103,513.98,515.9970000000001,517.427,523.568,527.693,530.958,535.083,536.531,541.433,545.169,548.045,551.781,555.046,557.452,560.329,561.814,566.716,570.84,574.106" y="450.192" svg_rhmargin="576.983" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther</text>
  <text x="348.437,352.561,356.686,360.81,364.935,366.952,371.077,373.094,377.292,381.416,385.54" y="459.149" svg_rhmargin="389.664" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2014;7:1625</text>
  <text x="389.652" y="459.149" svg_rhmargin="393.388" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="393.394,397.519,401.645" y="459.149" svg_rhmargin="403.662" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">30.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,354.19,356.207,360.331,364.067,366.124,371.488,373.505,375.59,380.955,384.691,388.815,392.551,394.581,399.946,401.963,403.992,408.505,412.241,414.31,419.675,421.692,423.721,426.986,429.392,431.431,435.167,437.184,439.201,441.238,445.751,449.876,454.0,457.736,459.776,463.9,468.025,472.149,474.628,477.893,482.018,486.142,488.16,492.284,496.02,498.04,503.405,509.547,514.912,516.975,521.099,526.464,531.43,535.555,537.553,539.571,542.448,544.469,548.206,551.083,553.959,558.084,561.42,563.437,567.173,569.579,572.844" y="468.106" svg_rhmargin="576.968" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[23] Ding C, Yang Z, Lv Z, et al. Long non-coding RNA PVT1 is associated</text>
  <text x="348.437,354.19,356.208,358.614,362.739,367.882,370.288,374.412,380.554,384.678,387.555,392.711,396.836,399.712,403.837,407.573,410.449,413.714,416.591,419.468,421.565,425.689,429.814,434.887,438.623,442.748,446.873,452.007,456.132,459.008,462.274,466.398,468.415,471.681,474.086,476.963,482.109,484.986,488.251,491.516,495.714,498.591,501.468,504.733,508.857,512.122,515.387,520.488,522.505,526.63,531.77,535.894,539.159,543.284,547.02,549.426,553.55,556.815,560.08,562.098,564.115,568.334,570.351,574.087" y="477.063" svg_rhmargin="576.964" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">with tumor progression and predicts recurrence in hepatocellular</text>
  <text x="348.437,351.702,355.438,358.315,361.58,363.597,367.722,371.846,377.988,381.724,384.264,388.389,392.125,394.531,396.548,399.813,403.938,406.429,409.306,411.323,413.799,419.941,424.065,427.33,431.455,433.472,436.021,440.534,443.799,446.205,448.611,451.1,455.225,459.349,463.474,467.598,469.615,473.74,475.757,479.955,484.079" y="486.021" svg_rhmargin="488.203" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoma patients. Oncol Lett 2015;9:955</text>
  <text x="488.184" y="486.021" svg_rhmargin="491.92" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="491.926,496.051,500.177" y="486.021" svg_rhmargin="502.194" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">63.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,354.66,358.785,362.521,366.645,370.381,373.152,378.517,380.534,383.3,388.664,392.789,395.544,403.016,405.033,407.846,415.318,419.054,423.178,426.914,429.671,435.813,437.83,440.612,443.877,446.283,449.002,452.738,454.755,456.772,459.546,461.952,466.077,469.342,472.219,475.484,479.22,482.096,485.453,489.578,492.312,495.578,499.702,503.826,506.703,509.968,512.845,515.721,517.739,521.863,525.988,528.763,532.888,535.294,538.061,540.467,544.591,547.856,550.646,552.664,556.788,560.053,565.418,571.56" y="495.034" svg_rhmargin="576.925" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Huang C, Yu W, Wang Q, et al. Increased expression of the lncRNA</text>
  <text x="348.437,352.561,357.926,362.828,366.953,369.809,371.826,374.70300000000003,377.576,381.311,384.188,387.065,391.189,394.454,396.472,400.208,402.614,405.879,410.004,412.836,418.589,420.606,423.096,427.221,430.013,434.137,438.261,442.386,445.26300000000003,448.097,452.222,455.098,459.223,462.959,467.144,471.269,474.145,476.163,479.04,481.883,483.901,488.026,490.84,494.965,498.701,502.825,506.09,508.967,512.232,515.968,518.447,520.465,523.73,526.554,529.819,533.555,537.68,540.945,544.21,547.087,549.966,554.091,557.827,560.233,562.25,565.515,569.64,572.046,574.922" y="503.992" svg_rhmargin="576.939" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 is associated with poor prognosis in pancreatic cancer patients.</text>
  <text x="348.437,355.909,357.926,362.051,365.316,368.193,371.928,375.664,378.199,385.671,388.936,393.061,395.602,399.727,403.852,407.976,412.1,414.118,418.242,422.367,426.491,428.508,432.633,436.757" y="512.9490000000001" svg_rhmargin="440.881" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Minerva Med 2015;106:143</text>
  <text x="440.903" y="512.9490000000001" svg_rhmargin="444.639" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="444.645,448.77" y="512.9490000000001" svg_rhmargin="450.787" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,354.66,358.785,362.521,366.645,370.381,372.189,377.554,379.57099999999997,381.316,385.829,387.846,391.971,393.788,397.524,399.541,401.271,408.743,412.479,416.604,420.34,422.133,428.358,430.375,432.167,435.433,437.839,439.594,443.33,445.347,447.364,449.174,453.687,457.811,461.077,466.441,472.583,477.94800000000004,479.729,483.854,489.218,494.12,498.245,500.024,504.148,507.884,511.15,514.026,517.291,521.416,525.54,528.417,531.682,534.559,537.435,539.453,543.674,547.799,549.57,551.587,554.4639999999999,556.202,559.938,561.702,565.826,569.951,574.075" y="521.906" svg_rhmargin="576.952" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Huang C, Liu S, Wang H, et al. LncRNA PVT1 overexpression is a poor</text>
  <text x="348.437,352.561,355.438,359.563,363.298,367.484,371.609,374.486,376.892,378.909,382.174,384.151,388.276,390.293,394.418,400.56,404.295,407.172,411.297,414.562,417.439,419.412,423.148,427.272,431.397,433.357,436.234,439.499,443.235,447.359,449.376,453.112,455.518,458.783,461.66,463.628,469.77,471.787,475.523,478.481,482.217,484.622,486.64,490.764,494.889,496.848,500.584,504.708,508.833,510.793,512.811,516.935,520.671,524.407,527.283,529.301,533.425,537.55,539.534,541.552,545.677,547.641,550.518,556.66,560.396,562.413,564.4300000000001,566.405,569.67,572.936,574.953" y="530.863" svg_rhmargin="576.97" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">prognostic biomarker and regulates migration and invasion in small cell</text>
  <text x="348.437,350.454,354.579,358.703,362.43899999999996,364.99,368.255,371.991,376.116,379.381,382.646,385.523,387.54,390.046,395.411,401.553,404.049,406.926,409.435,414.337,417.213,420.949,425.074,427.95,429.967,432.507,437.872,441.137,444.014,446.51,450.635,454.759,458.884,463.008,465.025,469.15,471.167,475.365,479.489,483.614" y="539.8199999999999" svg_rhmargin="487.738" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">lung cancer. Am J Transl Res 2016;8:5025</text>
  <text x="487.731" y="539.8199999999999" svg_rhmargin="491.467" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="491.471,495.596,499.721" y="539.836" svg_rhmargin="501.738" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,354.658,358.783,362.519,366.643,370.37899999999996,373.434,378.336,380.353,383.355,387.868,389.886,394.011,397.074,403.298,410.77,412.787,415.838,421.203,425.327,428.592,432.717,435.736,438.613,444.755,446.772,449.795,453.06,455.466,458.525,462.261,464.279,466.296,469.353,474.255,478.379,481.644,484.659,486.677,490.801,494.926,498.662,501.666,505.791,509.915,514.04,517.369,521.494,525.618,527.636,531.76,535.496,538.515,543.879,550.021,555.386,558.413,562.537,567.902,572.869" y="548.85" svg_rhmargin="576.993" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Huang T, Liu HW, Chen JQ, et al. The long noncoding RNA PVT1</text>
  <text x="348.435,350.841,354.965,359.09,362.355,364.761,366.859,370.983,375.108,377.985,381.201,384.937,387.814,391.122,394.858,398.096,401.361,405.485,411.627,415.751,419.017,421.423,423.44,427.564,431.3,434.603,437.868,441.992,446.117,450.241,453.977,457.242,461.367,465.491,469.616,472.493,475.815,481.18,487.321,492.68600000000004,495.939,500.064,503.8,507.051,509.927,514.052,518.176,522.301,526.098,528.115,532.24,535.976,539.193,545.335,547.352,552.717,555.123,559.247,563.456,567.581,570.826,572.843" y="557.807" svg_rhmargin="576.967" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">functions as a competing endogenous RNA by sponging miR-186 in</text>
  <text x="348.435,352.171,355.907,358.784,361.189,364.066,366.084,369.349,371.904,375.169,378.905,383.03,386.295,389.56,392.437,394.454,396.96,401.473,403.49,407.615,413.757,417.022,421.147,423.717,427.842,431.966,435.702,438.579,444.72,448.456,451.721,455.846,458.252,462.376,465.641,468.51800000000003,471.052,475.176,479.301,483.425,487.549,489.567,493.691,497.816,499.906,504.03,508.154" y="566.765" svg_rhmargin="512.278" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">gastric cancer. Biomed Pharmacother 2017;88:302</text>
  <text x="512.277" y="566.765" svg_rhmargin="516.013" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="516.019,520.143" y="566.765" svg_rhmargin="522.16" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,353.799,357.924,362.048,365.784,367.425,372.79,374.807,376.439,381.804,385.929,389.664,393.789,397.525,399.172,403.685,408.197,410.214,411.87,417.235,419.252,423.377,424.965,430.718,436.472,438.489,440.157,443.423,445.829,447.47,451.206,453.223,455.24,456.881,461.394,465.518,469.643,473.37899999999996,474.965,479.089,483.214,487.338,490.667,494.792,498.916,500.934,505.058,508.794,510.395,515.76,521.902,527.267,528.933,533.057,538.422,543.323,547.448,549.114,551.131,555.256,559.38,561.398,564.663,568.399,570.805,574.07" y="575.722" svg_rhmargin="576.947" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Kong R, Zhang EB, Yin DD, et al. Long noncoding RNA PVT1 indicates</text>
  <text x="348.435,352.171,356.372,360.497,364.621,368.746,371.623,375.817,379.941,382.818,386.942,390.678,394.864,398.988,401.865,403.883,406.76,410.964,415.089,417.495,421.679,425.415,429.151,432.027,434.433,437.382,439.399,442.664,446.849,450.114,453.85,457.975,461.24,464.505,467.382,471.622,475.358,479.482,483.607,487.778,491.902,494.779,498.904,505.125,509.25,511.656,514.921,517.798,521.962,525.227,528.493,530.51,532.527,536.758,540.882,543.759,547.884,549.901,551.918,554.324,557.676,560.553,564.289,566.695,568.712,572.836" y="584.679" svg_rhmargin="576.96" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">a poor prognosis of gastric cancer and promotes cell proliferation</text>
  <text x="348.435,350.841,354.965,357.842,361.967,366.091,369.827,373.952,375.702,378.967,383.091,385.109,388.845,392.11,396.234,399.5,401.905,403.923,407.188,411.018,413.035,415.053,418.789,420.486,423.362,426.627,430.363,434.488,436.505,440.241,442.647,444.664,448.789,452.525,454.272,458.396,462.52,466.645,468.387,472.123,476.248,480.373,482.049,486.174,490.298,494.423,496.44,498.149,505.621,509.745,511.762,513.512,518.877,522.613,526.737,530.003,533.268,536.145,537.888,542.013,546.137,550.262,554.386,556.404,560.528,564.653,566.67,570.794,574.919" y="593.636" svg_rhmargin="576.936" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">through epigenetically regulating p15 and p16. Mol Cancer 2015;14:82.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,352.947,356.683,360.808,363.911,368.813,370.83,373.945,379.311,383.047,387.172,390.273,396.026,398.043,401.157,405.67,407.687,410.794,416.159,418.176,421.281,424.547,426.95300000000003,430.068,433.804,435.822,437.839,440.952,445.465,449.59,453.714,457.45,460.567,464.691,468.815,472.94,475.346,478.611,482.735,486.86,488.877,493.002,496.738,499.852,505.216,511.358,516.723,519.863,523.988,529.353,534.254,538.379,541.518,544.395,547.66,550.537,554.273,557.538,560.415,563.514,567.25,570.127,573.265" y="602.593" svg_rhmargin="577.001" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[28] Lan T, Yan X, Li Z, et al. Long non-coding RNA PVT1 serves as a</text>
  <text x="348.435,351.7,355.825,361.967,366.091,369.356,371.847,373.865,377.989,381.72499999999997,384.773,388.038,392.162,396.287,400.411,404.147,407.412,411.537,415.661,419.785,422.66200000000003,425.758,431.123,437.265,442.63,445.713,448.119,452.244,455.12100000000004,458.128,464.27,466.288,471.734,474.14,478.264,482.389,486.513,488.919,493.043,497.168,500.248,502.654,506.779,509.829,513.954,516.831,520.955,527.097,531.221,533.627,536.8919999999999,539.988,542.394,546.518,549.783,552.8,555.206,559.33,565.472,569.597,572.473,574.491" y="611.607" svg_rhmargin="576.897" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">competing endogenous RNA for miR-186-5p to promote the tumori-</text>
  <text x="348.435,352.171,355.436,359.561,362.826,365.702,367.72,370.59700000000004,375.759,379.495,383.62,387.745,392.88,399.022,402.287,404.693,408.429,411.306,413.712,417.448,420.324,422.342,425.219,430.408,434.533,436.939,442.03,446.154,449.419,453.544,457.28,459.686,463.81,467.075,470.43,472.447,474.465,478.589,480.607,484.343,487.22,492.369,495.634,499.37,502.246,505.512,507.529,511.653,515.778,521.92,525.656,527.673,532.844,537.746,541.87,548.012,552.136,556.261,559.1379999999999,564.25,568.763,570.78,574.905" y="620.565" svg_rhmargin="576.922" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">genesis and metastasis of hepatocellular carcinoma. Tumour Biol</text>
  <text x="348.435,352.56,356.685,360.811,364.936,366.954,371.079,375.204,377.294,381.419,385.544,389.669,393.794,397.919,402.045,406.17,410.295,414.42,418.545,422.67,426.796,430.986,435.111,439.236,443.361" y="629.5219999999999" svg_rhmargin="445.378" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;39:1010428317705338.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,352.947,354.964,357.959,364.1,366.117,369.184,374.937,378.673,380.69,383.696,389.062,391.079,394.071,401.544,405.28,409.404,413.14,416.124,420.249,422.266,425.308,428.573,430.979,433.982,437.718,439.735,441.752,444.753,450.507,452.524,454.93,457.336,460.601,463.478,466.743,470.867,473.273,475.291,479.026,481.044,483.188,486.924,489.877,493.142,497.267,501.391,504.333,507.598,510.475,513.351,516.616,520.741,523.721,525.738,529.862,533.987,537.723,540.727,544.852,548.976,553.1,555.58,558.845,562.969,567.094,569.111,573.236" y="638.479" svg_rhmargin="576.972" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[29] Li Q, Dai Y, Wang F, et al. Differentially expressed long non-coding</text>
  <text x="348.435,353.8,359.942,365.306,368.183,371.847,375.583,379.708,383.833,387.437,389.843,393.967,397.23199999999997,400.816,404.941,407.818,411.942,415.678,419.864,423.988,426.865,429.271,431.288,434.553,438.174,442.299,446.423,448.829,452.094,456.219,458.625,460.642,464.378,466.395,470.033,472.051,476.176,479.784,483.049,487.174,489.191,493.315,496.192,499.457,502.799,505.205,508.941,510.95799999999997,514.534,517.799,521.535,525.659,528.99,532.255,535.131,537.148,540.725,546.867,550.132,554.33,558.455,560.472,564.208,567.085,573.227" y="647.436" svg_rhmargin="576.963" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">RNAs and the prognostic potential in colorectal cancer. Neoplasma</text>
  <text x="348.435,352.56,356.685,360.811,364.936,366.954,371.079,375.204,377.294,381.419,385.544" y="656.393" svg_rhmargin="389.668" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2016;63:977</text>
  <text x="389.65" y="656.393" svg_rhmargin="393.386" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="393.392,397.517,401.643" y="656.393" svg_rhmargin="403.66" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">83.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,352.947,354.964,357.505,361.63,367.383,369.4,371.961,378.186,382.311,384.83,387.707,392.22,394.237,396.735,404.207,407.943,410.511,415.876,417.893,420.375,423.64,426.046,428.596,432.331,434.349,436.366,438.913,444.278,448.403,451.279,454.544,458.28,462.405,464.422,468.158,470.564,472.581,476.706,480.831,483.413,487.538,489.944,492.484,494.89,499.014,502.279,504.785,506.803,510.927,515.052,518.788,521.338,525.463,529.587,533.712,536.118,539.383,543.507,547.632,549.649,553.774,557.51,560.057,565.421,571.563" y="665.407" svg_rhmargin="576.928" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[30] Li PD, Hu JL, Ma C, et al. Upregulation of the long non-coding RNA</text>
  <text x="348.435,352.56,357.924,362.826,366.951,370.374,374.498,377.375,381.499,387.721,391.846,394.252,397.517,400.394,403.821,407.086,409.963,414.087,418.212,422.336,426.072,429.808,433.073,436.809,438.826,442.255,445.132,449.256,453.381,457.117,463.259,467.383,471.507,474.384,477.855,481.121,484.386,486.403,488.42,491.858,495.123,498.859,501.735,505.001,507.018,511.142,515.267,521.409,525.145,528.592,532.716,535.593,539.718,543.453,546.33,549.595,552.472,555.349,557.446,561.57,565.695,569.124,573.249" y="674.365" svg_rhmargin="576.985" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 promotes esophageal squamous cell carcinoma progression by</text>
  <text x="348.435,352.171,355.436,357.842,359.859,363.984,367.71999999999997,371.961,375.697,378.574,382.846,386.582,390.783,396.926,401.05,403.067,406.333,409.598,413.799,415.816,419.552,422.42900000000003,426.611,429.488,433.612,437.737,441.861,445.658,448.923,453.142,457.266,459.672,463.913,470.055,472.072,477.437,479.843,483.967,488.092,492.217,496.452,500.188,504.312,508.437,512.665,517.178,522.543,526.279,530.403,534.604,536.6210000000001,540.84,546.982,551.106,554.371,558.496,560.902,564.638,567.514,571.25,574.515" y="683.322" svg_rhmargin="576.921" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">acting as a molecular sponge of miR-203 and LASP1. Oncotarget</text>
  <text x="348.435,352.56,356.684,360.808,364.933,366.95,371.075,373.092,377.29,381.414,385.538,389.663" y="692.279" svg_rhmargin="393.787" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;8:34164</text>
  <text x="393.789" y="692.279" svg_rhmargin="397.525" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="397.531,401.655,405.78" y="692.279" svg_rhmargin="407.797" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">76.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.434,352.17,356.295,360.419,364.155,367.539,370.416,372.433,375.759,383.231,387.356,390.725,396.479,398.496,401.837,406.35,408.367,412.492,415.839,419.963,421.98,425.306,428.572,430.978,434.32,438.056,440.074,442.091,445.489,450.001,454.126,458.25,461.986,465.33,469.454,473.579,477.703,480.109,483.374,487.499,491.623,493.64,497.765,501.501,504.841,510.206,516.348,521.713,525.08,529.204,534.569,539.535,543.66,546.962,551.087,553.963,558.088,564.23,568.354,570.76,574.116" y="701.236" svg_rhmargin="576.993" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[31] Song J, Wu X, Liu F, et al. Long non-coding RNA PVT1 promotes</text>
  <text x="348.435,352.171,354.188,357.924,361.189,365.314,367.331,371.067,373.944,376.042,378.919,381.938,385.674,389.798,393.923,396.961,399.367,403.491,409.633,413.757,416.634,419.693,423.817,426.694,430.818,434.554,437.431,440.696,443.573,446.449,448.547,452.671,456.796,459.828,463.953,467.68899999999996,470.713,473.59,476.855,480.591,484.715,486.733,490.469,492.875,494.976,499.1,502.836,505.861,512.002,514.02,519.385,521.791,525.915,530.039,534.164,536.181,542.405,547.866,551.991,555.009,558.745,562.87,564.887,567.7639999999999,570.826,572.843" y="710.193" svg_rhmargin="576.967" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">glycolysis and tumor progression by regulating miR-497/HK2 axis in</text>
  <text x="348.435,352.56,355.436,357.842,361.107,365.232,368.108,371.844,374.721,377.986,382.11,388.343,392.079,394.096,396.62,401.134,403.151,407.275,410.541,414.665,417.93,424.072,426.609,431.122,433.14,437.264,441.389,445.513,449.249,452.12600000000003,454.614,459.979,463.244,466.12100000000004,468.673,474.038,478.163,484.304,490.446,494.571,498.696,501.212,505.337,509.461,513.586,517.71,519.727,523.852,527.976,532.101,534.118,538.243,542.367" y="719.15" svg_rhmargin="546.491" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">osteosarcoma. Biochem Biophys Res Commun 2017;490:217</text>
  <text x="546.576" y="719.15" svg_rhmargin="550.312" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="550.318,554.442,558.567" y="719.15" svg_rhmargin="560.584" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">24.</text>
  <text svg_rhmargin="181.152" x="71.887,78.438,82.503,85.152,89.217,91.536,94.166,98.231,99.642,101.794,104.427,110.979,115.044,119.603,121.013,125.078,126.489,130.721,134.786,137.422,139.326,143.726,148.126,152.525,156.925,158.83,161.402,165.801,170.201,172.353,176.752,181.151" y="9.870999999999981" style="fill:#171615;font-family:NCNEAI+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Ma et al. Medicine (2018) 97:49 </text>
  <text x="542.723,549.944,554.503,559.317,561.31,565.869,567.861,572.508" y="9.870999999999981" svg_rhmargin="577.067" style="fill:#171615;font-family:NCNOOH+AdvOT34fe1490.B;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Medicine</text>
  <text x="320.032,324.432" y="739.625" svg_rhmargin="328.832" style="fill:#171615;font-family:NCNEJG+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">10</text>
 </g>
</svg>
